CNBX — CNBX Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for CNBX Pharmaceuticals, fiscal year end - August 31st, USD millions except per share, conversion factor applied.

	2019 August 31st	2020 August 31st	2021 August 31st	2022 August 31st	2023 August 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	3.52	0.778	1.39	0.118	0.13
Net Total Receivables	0.5	0	—	—	—
Prepaid Expenses
Total Current Assets	4.31	0.93	1.59	0.198	0.224
Net Property, Plant And Equipment	1	0.863	0.643	0.437	0.275
Net Intangible Assets
Long Term Investments
Total Assets	15.2	2.22	3.08	0.811	0.499
Payable / Accrued
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.439	0.455	1.27	2.44	2.52
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	0.439	0.455	1.27	2.44	2.52
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	14.7	1.76	1.81	-1.63	-2.02
Total Liabilities & Shareholders' Equity	15.2	2.22	3.08	0.811	0.499
Total Common Shares Outstanding